389 articles in this topic
Scientists identify protein and metabolic markers in blood that can catch lung cancer in early stages when treatment is most effective.
New liquid biopsy combining DNA methylation and protein markers shows promise for early multi-cancer detection across nine major cancer types.
Combination immunotherapy before surgery achieved 60% four-year survival in liver cancer, with biomarkers predicting response.
New research reveals how gut microbiome restoration could treat inflammatory bowel disease and boost cancer treatments.
Specific bacterial metabolic pathways in the gut determine whether cancer immunotherapy works by controlling immune responses.
Comprehensive study of 670 brain tumor samples uncovers why immunotherapies fail and how tumors evade treatment through immune system changes.
Spatial multi-omics reveals how specific fibroblasts create immunosuppressive environments that fuel colorectal cancer spread to the liver.
Massive spatial analysis reveals conserved fibroblast subtypes that control immune infiltration and therapy response across cancer types.
New blood test identifies early-stage breast and lung cancers by measuring epigenetic chaos in cell-free DNA fragments.
Combination therapy with olaparib and irinotecan demonstrated activity in pediatric tumors, particularly those with genetic instability.
New study shows circulating tumor cells can predict treatment response and reveal drug resistance patterns.
Switching between different drug types prevents resistance in breast cancer therapy, offering hope for extended treatment options.
